Last reviewed · How we verify
NCT03348553
Juice Plus+OMEGA Study
NA trial testing control group in Healthy in 72 participants. Completed in 3 February 2020.
30 April 2019
Quick facts
| Lead sponsor | Green Beat |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 72 |
| Start date | 1 September 2017 |
| Primary completion | 30 April 2019 |
| Estimated completion | 3 February 2020 |
| Sites | 2 locations across Austria |
Drugs / interventions tested
- control group — full drug profile →
- Omega2
- Omega4
- Omega2+OGV
Conditions studied
- Healthy — all drugs for Healthy →
Sponsor
Green Beat
Who can join
Adults 20 to 65, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this randomized, controlled clinical study firstly the bioavailability of fatty acids and micronutrients of JP+® Omega Blend will be analysed. Secondly, the effect of the constituents contained in the nutraceuticals on blood lipid values will be determined. Thirdly, it will be examined, whether a dose-dependent effect of the supplementation of JP+® Omega Blend exists. Fourthly, the effect of a combined consumption of JP+® Omega Blend and Juice Plus+® Orchard, Garden and Vineyard blend (JP+® OGV) is investigated.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03348553
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of control group
Trials testing the same drug.
- NCT07485335 — A Bundled Intervention to End Opioid Overdoses · Phase 4 · not yet recruiting
- NCT07276802 — The TRIBECA Study (TRIessence/Byqlovi for Easier CAtaract Surgery) · Phase 4 · not yet recruiting
- NCT07475585 — Effects of Auricular Point Pressing With Pellets in Children With Insufficient Hyperopia Reserve · NA · not yet recruiting
- NCT07478406 — Relatıonshıp Between Pelvıc Floor and Venous Insuffıcıency · NA · enrolling by invitation
- NCT07318246 — Team Work and Creative Self-Efficacy · NA · recruiting
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other Green Beat trials
Trials by the same sponsor.
- NCT04003935 — Juice Plus Inflammaging and Cardiovascular Disease Prevention Study · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03348553 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Green Beat
- Last refreshed: 6 August 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03348553.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing